Pacific Biosciences of California, Inc.
US ˙ NasdaqGS ˙ US69404D1081

SecurityPACB / Pacific Biosciences of California, Inc.
InsiderChristian O Henry
This page shows the track record and history of HENRY CHRISTIAN O insider trades in Pacific Biosciences of California, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Christian O Henry in PACB / Pacific Biosciences of California, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Max		 Price at
Max		 Max
Profit ($)		 Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PACB / Pacific Biosciences of California, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Christian O Henry in PACB / Pacific Biosciences of California, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares		 Reported
Price		 Adjusted
Shares		 Adjusted
Price		 Cost Basis Days to
Min		 Price at
Min		 Max Loss
Avoided ($)		 Max Loss
Avoided (%)
2025-03-03 12,497 1.4070 12,497 1.4070 17,583 85 0.9102 -6,208 -35.31
2025-02-18 259,909 1.8780 259,909 1.8780 488,109
2024-09-16 98,907 1.7460 98,907 1.7460 172,692
2024-03-04 14,177 4.8710 14,177 4.8710 69,056
2024-02-20 1,979 5.2610 1,979 5.2610 10,412
2024-02-16 79,038 5.9580 79,038 5.9580 470,908
2023-09-18 96,844 10.1220 96,844 10.1220 980,255
2023-03-03 13,769 9.4930 13,769 9.4930 130,709
2023-02-17 1,530 10.2710 1,530 10.2710 15,715
2022-12-01 45,000 10.8440 45,000 10.8440 487,980
2022-09-15 91,307 5.7765 91,307 5.7765 527,435
2022-02-17 2,122 11.0900 2,122 11.0900 23,533
2021-09-16 90,520 26.9100 90,520 26.9100 2,435,893

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

PACB / Pacific Biosciences of California, Inc. Insider Trades
Insider Transaction History
File
Date		 Trade
Date		 Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price		 Unit
Price		 Units
Changed		 Value
Changed (1K)		 Remaining
Options		 Remaining
Shares
2025-03-21 2025-03-19 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 920,810 3,146,167
2025-03-05 2025-03-03 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 1.4070 -12,497 -18 2,225,357
2025-02-19 2025-02-18 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 1.8780 -259,909 -488 2,237,854
2024-09-17 2024-09-16 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 1.7460 -98,907 -173 2,497,763
2024-03-06 2024-03-04 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 4.8710 -14,177 -69 2,596,670
2024-02-26 2024-02-22 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 1,605,769 2,610,847
2024-02-21 2024-02-20 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 5.2610 -1,979 -10 1,005,078
2024-02-21 2024-02-16 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 5.9580 -79,038 -471 1,007,057
2023-12-15 2023-12-14 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.0000 -20,000 -200 1,086,095
2023-09-19 2023-09-18 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.1220 -96,844 -980 1,106,095
2023-09-12 2023-09-11 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.4520 -10,000 -105 1,202,939
2023-08-18 2023-08-17 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.5000 -10,000 -105 1,212,939
2023-03-06 2023-03-03 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 9.4930 -13,769 -131 1,222,939
2023-03-06 2023-03-02 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 594,687 1,236,708
2023-02-22 2023-02-17 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.2710 -1,530 -16 642,021
2022-12-02 2022-12-01 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 10.8440 -45,000 -488 643,551
2022-09-19 2022-09-15 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 5.7765 -91,307 -527 688,551
2022-03-04 2022-03-02 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 11.70 642,300 642,300
2022-03-04 2022-03-02 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 107,500 779,858
2022-02-22 2022-02-17 4 HENRY CHRISTIAN O PACB Commons Stock S - Sale D 11.0900 -2,122 -24 672,358
2021-09-20 2021-09-16 4/A HENRY CHRISTIAN O PACB Common Stock S - Sale D 26.9100 -90,520 -2,436 674,480
2021-09-17 2021-09-16 4 HENRY CHRISTIAN O PACB Common Stock S - Sale D 26.9100 -90,520 -2,436 674,480
2021-02-18 2021-02-16 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 46.37 30,000 30,000
2021-02-18 2021-02-16 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 15,000 765,000
2020-09-17 2020-09-15 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 7.32 1,500,000 1,500,000
2020-09-17 2020-09-15 4 HENRY CHRISTIAN O PACB Common Stock A - Award D 750,000 750,000
2020-08-06 2020-08-04 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 3.89 97,785 97,785
2020-03-16 2020-03-16 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 2.45 35,000 35,000
2018-07-31 2018-07-27 4 HENRY CHRISTIAN O PACB Stock Option (right to buy) A - Award D 3.66 35,000 35,000
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)